INITIAL ANTIBIOTIC SELECTION FOR THE TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN CHILDREN AT THE 24-HOUR OUTPATIENT CLINICS OF THE VIETNAM NATIONAL CHILDREN'S HOSPITAL

Sơn Phùng Đức, Thúy Nguyễn Thị Diệu, Thanh Vũ Thị, Hùng Nguyễn Việt, Hoàng Nguyễn Đình

Main Article Content

Abstract

Introduction: Identification of the pathogens causing pneumonia is the most important which helps to use appropriate antibiotics, thereby reducing hospitalization duration and treatment costs. Objective: To describe the clinical, paraclinical, microbiological characteristics and initial antibiotic choices for children diagnosed with community-acquired pneumonia at the 24-hour Examination and Treatment Department, Vietnam National Children’s Hospital, between September 2024 and March 2025. Methods: There was a cross-sectional descriptive study. Results: We recruited 160 children with community-acquired pneumonia treated at the 24-hour Examination and Treatment Department.  The median age was 19 months of age. The common clinical symptoms were cough (98.1%), fever (75%), crackles (96.9%), and tachypnea (28.7%). The average white blood cell was 13.13 G/L. Haemophilus influenzae was the most frequently identified pathogen by both PCR (30%) and sputum culture (28.75%), followed by S. pneumoniae and M. catarrhalis. Ceftriaxone and Cefotaxim were the primary choices for treatment of pneumonia, with the sensitivity rates of H. influenza was 98%.  The sensitivity rates of Ceftriaxone for S. pneumonia was 94.7%. Third-generation cephalosporins were the most common empirical treatment, with ceftriaxone monotherapy being the most frequently used (46.88%), followed by cefotaxime (29.38%). Conclusion: The pathogens caused community-acquired pneumonia was unchanged. Third-generation cephalosporins remain the first-line treatment.

Article Details

References

1. Tráng LV. Nghiên cứu tính kháng kháng sinh trong viêm phổi do vi khuẩn ở trẻ em tại bệnh viện Nhi Thanh Hóa. Đại học Y Hà Nội; 2012.
2. Phúc TT. Xác Định Tỉ Lệ Nhiễm và Tính Kháng Kháng Sinh Của H.Influenza và S.Pneumoniae ở Trẻ Em Dưới 5 Tuổi Tại Bệnh Viện Sản Nhi Nghệ An Năm 2019. Đại học Y Hà Nội; 2020.
3. Rambaud-Althaus C, Althaus F, Genton B, D’Acremont V. Clinical features for diagnosis of pneumonia in children younger than 5 years: a systematic review and meta-analysis. Lancet Infect Dis. 2015;15(4): 439-450. doi:10.1016/ S1473-3099(15)70017-4
4. Harding AT, Heaton NS. The Impact of Estrogens and Their Receptors on Immunity and Inflammation during Infection. Cancers. 2022; 14(4):909. doi:10.3390/cancers14040909
5. Patel N, AL-Sayyed B, Gladfelter T, Tripathi S. Epidemiology and Outcomes of Bacterial Coinfection in Hospitalized Children With Respiratory Viral Infections: A Single Center Retrospective Chart Review. J Pediatr Pharmacol Ther JPPT. 2022;27(6):529-536. doi:10.5863/ 1551-6776-27.6.529
6. Atkinson TP, Waites KB. Mycoplasma pneumoniae Infections in Childhood. Pediatr Infect Dis J. 2014;33(1):92-94. doi:10.1097/ INF.0000000000000171
7. Dagan R, Klugman KP. Impact of conjugate pneumococcal vaccines on antibiotic resistance. Lancet Infect Dis. 2008;8(12):785-795. doi:10. 1016/S1473-3099(08)70281-0
8. Song JH, Jung SI, Ko KS, et al. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob Agents Chemother. 2004;48(6):2101-2107. doi:10.1128/ AAC.48.6.2101-2107.2004